Pharmacokinetic considerations in obesity

被引：137

作者：

Blouin, RA ^{[1
]}

Warren, GW

机构：

[1] Univ Kentucky, Coll Pharm, Div Pharmaceut Sci, Lexington, KY 40536 USA

[2] Univ Kentucky, Grad Ctr Toxicol, Lexington, KY 40536 USA

来源：

关键词：

D O I：

10.1021/js980173a

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

引用

页码：1 / 7

页数：7

共 94 条

[1] PHENYTOIN DISPOSITION IN OBESITY - DETERMINATION OF LOADING DOSE
ABERNETHY, DR
GREENBLATT, DJ
[J]. ARCHIVES OF NEUROLOGY, 1985, 42 (05) : 468 - 471
[2] DRUG DISPOSITION IN OBESE HUMANS - AN UPDATE
ABERNETHY, DR
GREENBLATT, DJ
[J]. CLINICAL PHARMACOKINETICS, 1986, 11 (03) : 199 - 213
[3] ABERNETHY DR, 1983, J LAB CLIN MED, V101, P873
[4] ABERNETHY DR, 1984, AM J GASTROENTEROL, V79, P91
[5] PROLONGED ACCUMULATION OF DIAZEPAM IN OBESITY
ABERNETHY, DR
GREENBLATT, DJ
DIVOLL, M
SHADER, RI
[J]. JOURNAL OF CLINICAL PHARMACOLOGY, 1983, 23 (8-9) : 369 - 376
[6] OBESITY, SEX, AND ACETAMINOPHEN DISPOSITION
ABERNETHY, DR
DIVOLL, M
GREENBLATT, DJ
AMEER, B
[J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1982, 31 (06) : 783 - 790
[7] ABERNETHY DR, 1981, J PHARMACOL EXP THER, V217, P681
[8] ABERNETHY DR, 1988, J CARDIOVASC PHARM, V11, P209
[9] DIGOXIN DISPOSITION IN OBESITY - CLINICAL PHARMACOKINETIC INVESTIGATION
ABERNETHY, DR
GREENBLATT, DJ
SMITH, TW
[J]. AMERICAN HEART JOURNAL, 1981, 102 (04) : 740 - 744
[10] ABERNETHY DR, 1982, J PHARM SCI, V7, P942